Back to Authors

Starling, Amaal J.

https://orcid.org/0000-0003-1334-1157

A5070710024 | I4210125099

Mayo Clinic in Arizona

Citations 86

Patient Gains in Daily Functioning and Reductions in Disability with Galcanezumab among Patients with Episodic and Chronic Migraine (P1.10-003)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.10-003

Examining the Spectrum of Reversibles: RCVS and PRES at Mayo Clinic Arizona (S53.007)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s53.007

A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.004

Real World Efficacy, Tolerability and Safety of Ubrogepant (2485)

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.2485

Impact of Fremanezumab on Headache-related Disability in Patients With Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medication Classes in the Open–label Extension of the Phase 3b FOCUS Study (4416)

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.4416

Benefit of Migraine Prevention with Erenumab in Patients Receiving Background Standard-of-care Acute Treatment (1381)

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1381

Changes in Acute Headache Medication Use Among Patients With Chronic Migraine and Medication-Overuse Headache: An Exploratory Analysis of PROMISE-2 (P16-2.002)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.433

A Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM) (P11-2.005)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.2994

The Effect of Pharmacogenomic Data on Adequate Dosages of Verapamil for The Prevention of Primary Headache Disorders-a pilot exploratory study (P11-2.004)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.2390

Treatment with Eptinezumab for Migraine Prevention in People with Chronic Migraine and Medication-Overuse Headache: A Plain Language Summary

Pain Management | June 26, 2023 | Volume: 13 | Issue: 6 | Pages: 317-327

10.2217/pmt-2023-0047 | PMID 37357842